ATE493649T1 - Verfahren zur diagnose von polyzystischer nierenkrankheit - Google Patents

Verfahren zur diagnose von polyzystischer nierenkrankheit

Info

Publication number
ATE493649T1
ATE493649T1 AT07700227T AT07700227T ATE493649T1 AT E493649 T1 ATE493649 T1 AT E493649T1 AT 07700227 T AT07700227 T AT 07700227T AT 07700227 T AT07700227 T AT 07700227T AT E493649 T1 ATE493649 T1 AT E493649T1
Authority
AT
Austria
Prior art keywords
kidney disease
polycystic kidney
diagnosing
diagnosing polycystic
pkd
Prior art date
Application number
AT07700227T
Other languages
English (en)
Inventor
Gerd Walz
Original Assignee
Universitaetsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Freiburg filed Critical Universitaetsklinikum Freiburg
Application granted granted Critical
Publication of ATE493649T1 publication Critical patent/ATE493649T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
AT07700227T 2006-01-17 2007-01-17 Verfahren zur diagnose von polyzystischer nierenkrankheit ATE493649T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06000963A EP1808694A1 (de) 2006-01-17 2006-01-17 Verfahren zur Diagnose von polyzystischer Nierenerkrankung
PCT/EP2007/000384 WO2007082733A1 (en) 2006-01-17 2007-01-17 Method for diagnosing polycystic kidney disease

Publications (1)

Publication Number Publication Date
ATE493649T1 true ATE493649T1 (de) 2011-01-15

Family

ID=35945115

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07700227T ATE493649T1 (de) 2006-01-17 2007-01-17 Verfahren zur diagnose von polyzystischer nierenkrankheit

Country Status (8)

Country Link
US (1) US20110229895A1 (de)
EP (3) EP1808694A1 (de)
AT (1) ATE493649T1 (de)
DE (1) DE602007011566D1 (de)
DK (2) DK2341344T3 (de)
ES (2) ES2356481T3 (de)
PL (2) PL1974210T3 (de)
WO (1) WO2007082733A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007090872A2 (en) * 2006-02-09 2007-08-16 Novartis Ag Antibodies against secreted fri zzled related protein-4 (sfrp-4 )
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
WO2009132815A1 (en) 2008-04-30 2009-11-05 Roche Diagnostics Gmbh Use of sfrp-3 in the assessment of heart failure
WO2010079076A2 (de) * 2008-12-17 2010-07-15 Mosaiques Diagnostics And Therapeutics Ag Autosomal dominante polyzystische nierenerkrankung (adpkd)
JP2013510321A (ja) * 2009-11-07 2013-03-21 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
WO2011079280A2 (en) * 2009-12-23 2011-06-30 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating kidney disorders in a canine
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
MX361944B (es) 2010-07-23 2018-12-19 President And Fellows Of Harvard College Star Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales.
JP2013541323A (ja) 2010-07-23 2013-11-14 プレジデント アンド フェロウズ オブ ハーバード カレッジ 貪食細胞を用いて疾患または症状のシグネチャを検出する方法
WO2012012704A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting kidney-associated diseases or conditions
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
EP2813851B1 (de) * 2011-02-24 2016-06-08 Hill's Pet Nutrition, Inc. Zusammensetzungen und Verfahren zur Diagnostizierung von Nierenerkrankungen bei Katzen
US10494675B2 (en) 2013-03-09 2019-12-03 Cell Mdx, Llc Methods of detecting cancer
US11585814B2 (en) 2013-03-09 2023-02-21 Immunis.Ai, Inc. Methods of detecting prostate cancer
EP3004873B1 (de) * 2013-06-05 2024-01-24 Astute Medical, Inc. Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
US10871495B2 (en) 2014-08-04 2020-12-22 Genzyme Corporation Biomarkers of polycystic kidney disease and uses thereof
WO2016040843A1 (en) 2014-09-11 2016-03-17 Harry Stylli Methods of detecting prostate cancer
CA2982436C (en) 2015-03-13 2023-09-12 Indiana University Research And Technology Corporation Targeting cgmp-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods
US10531837B1 (en) 2015-09-25 2020-01-14 Cerner Innovation, Inc. Predicting chronic kidney disease progression
MX2018006250A (es) 2015-11-18 2018-09-05 Genzyme Corp Biomarcador de enfermedad poliquistica renal y usos del mismo.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0879885A1 (de) * 1997-05-23 1998-11-25 Smithkline Beecham Corporation GEN für ein sekretiertes-Maus-sFRP-1-Protein ähnliches Protein
US6638726B1 (en) * 2000-01-06 2003-10-28 Mount Sinai School Of Medicine Of New York University Screening methods for compounds useful in the treatment of polycystic kidney disease
AU2001280680A1 (en) * 2000-07-19 2002-01-30 Genzyme Corporation Phosphatonin-related gene and methods of use thereof
US20030143610A1 (en) * 2002-01-08 2003-07-31 Millennium Pharmaceuticals, Inc. Methods for the treatment of metabolic disorders, including obesity and diabetes
US7879544B2 (en) * 2002-07-29 2011-02-01 Hmgene Inc. Methods of identifying adipocyte specific genes, the genes identified, and their uses
US20040191818A1 (en) * 2003-02-26 2004-09-30 O'toole Margot Mary Compositions and methods for diagnosing and treating autoimmune diseases
WO2005070448A2 (en) * 2004-01-21 2005-08-04 Five Prime Therapeutics, Inc. Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease
MXPA06012446A (es) * 2004-04-29 2007-01-17 Genzyme Corp Metodos y composiciones para el tratamiento de enfermedades poliquisticas.

Also Published As

Publication number Publication date
ES2356481T3 (es) 2011-04-08
EP1974210A1 (de) 2008-10-01
ES2475540T3 (es) 2014-07-11
EP1974210B1 (de) 2010-12-29
PL2341344T3 (pl) 2014-09-30
EP1808694A1 (de) 2007-07-18
EP2341344B1 (de) 2014-04-30
PL1974210T3 (pl) 2011-05-31
DE602007011566D1 (en) 2011-02-10
EP2341344A1 (de) 2011-07-06
DK2341344T3 (da) 2014-06-30
US20110229895A1 (en) 2011-09-22
WO2007082733A1 (en) 2007-07-26
DK1974210T3 (da) 2011-02-21

Similar Documents

Publication Publication Date Title
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
DE112006000054A5 (de) Verfahren zur Diagnose eines Abgasnachbehandlungssystems
WO2006023412A3 (en) Biomarkers for osteoarthritis
NO20070949L (no) Transkriptomdiagnostikk i spytt
ATE511656T1 (de) Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
WO2004112589A3 (en) Method for the detection of gene transcripts in blood and uses thereof
ATE528410T1 (de) Verfahren und zusammensetzungen zur diagnose von altersbedingter maculadegeneration
ATE535805T1 (de) Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen
WO2010059242A3 (en) Neurodegenerative disease diagnostic compositions and methods of use
ATE478335T1 (de) Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
DE602006014798D1 (de) Vorrichtung und Verfahren zur Unterscheidung zwischen akuter und chronischer Myokardial-Nekrose bei symptomatischen Patienten
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
ATE479100T1 (de) Verfahren zur diagnose von lawsonia intracellularis
WO2012178188A3 (en) Molecular diagnostic panel of eosinophilic gastrointestinal disorders
WO2006002240A3 (en) Computer systems and methods for constructing biological classifiers and uses thereof
ATE451475T1 (de) Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben
WO2007134028A3 (en) Biomarkers for depression and methods using the same
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
ATE525481T1 (de) Verfahren zur diagnose thromboembolischer erkrankungen und koronarer herzerkrankungen
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
ATE406579T1 (de) Verfahren zur diagnose von tumoren
ATE553127T1 (de) Oligoklonale anti-clusterin-antikörper zur diagnose und vorhersage der aggressivität von tumoren, diagnostisches verfahren und damit in zusammenhang stehende kits
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1974210

Country of ref document: EP